1. Transforming Oncology Clinical Development with Adaptive Studies 1 Cyrus Mehta, PhD, Cytel Inc. Dr. John Grous, MD, Medelis 2. Cyrus Mehta, PhD.,…
1. Adaptive Designs for Phase 3 Oncology Trials: Case Study and Extensions Cytel User Group Meeting, Paris October 13, 2011 Cyrus Mehta, Ph.D. President, Cytel Inc., Cambridge,…
Information-Based Sample Size Re-estimation for Binomial Trials Keaven Anderson, Ph.D. Amy Ko, MPH Nancy Liu, Ph.D. Yevgen Tymofyeyev, Ph.D. Merck Research Laboratories June…